GlassScriptPhysician profile
Persephone Jones
NPI 1669406328
$597.48
in general payments reported to CMS, 2019-2025
11 companies · $66.33 in 2025
The $66.33 reported for 2025 was less than what a typical Developmental - Behavioral Pediatrics provider received nationally (typical 2025 total: $79.84).
See the full distribution for Developmental - Behavioral Pediatrics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $93.41 · 2021: $32.76 · 2022: $14.20 · 2023: $31.19 · 2024: $58.58 · 2025: $66.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $127.56 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $122.31 | 2019 | |
| Tris Pharma INC | $92.23 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Corium, LLC | $72.87 | 2023-2025 | Azstarys |
| Neos Therapeutics, LP | $49.02 | 2019-2020 | |
| Ucb, INC. | $37.73 | 2024-2025 | Briviact |
| Supernus Pharmaceuticals, INC. | $32.76 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $18.93 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.21 | 2025 | Relexxii |
| Shire North American Group INC | $15.00 | 2019 | |
| Adlon Therapeutics L.P. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Persephone Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.